Cci-779 for treating mantle cell lymphoma

Details Cci-779 for treating mantle cell lymphoma Cci-779 for treating mantle cell lymphoma

A - Human Necessities

61

K

A61K 31/436 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2543665

This invention provides the use of rapamycin 42-ester with 3-hydroxy-2- (hydroxymethyl)-2-methylpropionic acid (CCI-779) in the treatment or inhibition of mantle cell lymphoma.

L'invention concerne l'utilisation de rapamycine 42-ester avec de l'acide 3-hydroxy-2-(hydroxyméthyl)-2-méthylpropionique dans le traitement ou l'inhibition de lymphomes à cellules du manteau.

Affiliated with

Also associated with

Rating

Cci-779 for treating mantle cell lymphoma does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cci-779 for treating mantle cell lymphoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cci-779 for treating mantle cell lymphoma will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2029648